Cardiac ganglia develop destructive ganglionitis in chronic Chagas' disease and rheumatic heart disease. This ganglionitis is associated with periganglionic infiltrations and is suspected of developing secondary to epicardial inflammation. If so, it would be expected that cardiac ganglia (1) are equipped with an inventory of immune competent cells allowing the initiation of inflammatory processes, and (2) are not effectively protected from the milieu of the surrounding tissue by metabolically active diffusion barriers. These problems were addressed in specified pathogen-free rats by electron microscopy and immunohistochemistry with markers for dendritic cells, monocytes/macrophages, and perineurial barriers. In contrast to nerve fascicles, cardiac ganglia are only partially enveloped by perineurial cells. Inside the ganglia, ramified cells with major histocompatibility complex class II antigen (reacting with monoclonal antibody OX6) on their surface and exhibiting an ultrastructure typical of dendritic cells are numerous, comprising nearly 5% of all cells within ganglia. The ratio of the number of these cells to that of neurons is 1:2. Cells reacting with monoclonal antibodies ED1 and ED2, markers for monocytes/macrophages, constitute 1.8% and 1.6% of the ganglionic cell population, respectively. Such cells are less frequent in the cervical trunk of the vagus nerve. Thus, the inventory of immune competent cells in rat cardiac ganglia is consistent with the view that the abundance of antigen-presenting cells correlates with the permeability of the barriers providing protection from blood-borne and tissue-borne factors.